#“Low Cost ICD Implantation India” | Explore Tumblr posts and blogs

healthcare-market · 4 years ago

Text

Ventricular Tachycardia Treatment Market Report Analysis With Industry Share Insights Shared in Detailed Report

Ventricular tachycardia is a condition, wherein the pulse rate is more than 100 beats per minute with minimum three continuous irregular heartbeats. This condition occurs in bottom chambers of the heart and develops as an early or late complication of heart attack. Patients suffering from cardiomyopathy, myocarditis, or valvular heart disease are at a higher risk of developing ventricular tachycardia. Major reasons for ventricular tachycardia are changes in pH values, changes in blood chemistry, and lack of oxygen. If the heart rate during this condition is very high and lasts for longer time, the patient may complain of chest discomfort, fainting, palpitation, dizziness, or shortness of breath. If left untreated, it leads to ventricular fibrillation (a leading cause of cardiac death).

Request a PDF Brochure - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=34034

Diagnostic techniques such as continuous ambulatory electrocardiogram, intra-cardiac electrophysiology study (EPS), electrocardiogram (ECG), loop recorder, and blood tests are utilized for confirming ventricular tachycardia. Treatment of the disease depends on its symptoms and seriousness. Based on treatment, the ventricular tachycardia market has been segmented into emergency treatment and long-term treatment. The emergency segment has been sub-segmented into cardiopulmonary resuscitation (CPR), electric defibrillation (electric shock), and anti-arrhythmic medications (such as procinamide, lidocaine, amiodarone, and solatol that are injected through vein). Long-term treatment includes oral antiarrhythmic medication. However, antiarrhythmic agents are not always prescribed due to their severe side effects. Other long-term treatment options are implantation of an implantable cadioverter defibrillator (ICD), ablation procedure using a radiofrequency catheter, and cardiac resynchronization therapy. The catheter ablation procedure sub-segment is expected to expand significantly during the forecast period, owing to promising success rate of the procedure. Rising incidence of cardiac diseases such as cardiomyopathy, myocarditis, and valvular heart disease is anticipated to be the primary factor fueling the ventricular tachycardia market during the forecast period. Moreover, growing geriatric population suffering from heart diseases and changing lifestyle are other factors likely to drive the market in the near future. Furthermore, advancements in technology and improvements in existing treatment therapies are anticipated to fuel the ventricular tachycardia market during the forecast period. However, high cost of treatment is a major factor restraining the market.

Request for Analysis of COVID19 Impact on Ventricular Tachycardia Treatment Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=34034

In terms of geography, the global ventricular tachycardia market can be classified into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. The market in North America and Europe is mature, owing to high prevalence of the disease and economic stability in these regions, which allows patients to afford expensive treatments. The market in Asia Pacific is expanding at a rapid pace, led by growing economies of China, Japan, and India. However, factors such as high cost of therapy, low awareness among patients, and lack to access to medical facilities are restraining the ventricular tachycardia market in Middle East & Africa.

Major players operating in the global ventricular tachycardia market are CardioDx, Inc., Advanced Instrumentations Inc., Cameron Health, Inc., Bexen Cardio, CU Medical Systems, Inc., Biotronik SE & Co. KG, Pfizer Inc., Heritage Pharmaceuticals Inc., and Baxter International Inc. Some of the major institutes that are currently conducting clinical research trials on ventricular tachycardia patients are National Heart, Lung & Blood Institute, Meshalkin Research Institute of Pathology of Circulation, Institut de Recherches Internationales Servier, University of Pittsburgh (Canada), Emory University, Lawson Health Research Institute, Vanderbilt University, and Duke University.

Pre-Book Ventricular Tachycardia Treatment Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=34034&ltype=S

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

More Trending Reports by Transparency Market Research:

https://www.prnewswire.com/news-releases/magnifying-prevalence-of-malnutrition-and-other-disorders-to-add-extra-stars-of-growth-global-medical-foods-market-to-reach-valuation-of-us-33-3-bn-by-2030--301123806.html

https://www.prnewswire.com/news-releases/technological-strides-in-ultrasound-devices-market-expand-scope-of-diagnosing-complex-diseases-market-to-clock-cagr-of-5-6-from-2018-to-2026-tmr-301129995.html

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of analysts, researchers, and consultants, uses proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Transparency Market Research,

90 State Street, Suite 700,

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com

0 notes

healthcare00897 · 6 years ago

Text

Electrosurgery Market Outlook by Product Overview, Application and Regions 2026

Electrosurgery involves application of electrical current to a biological tissue to cut, coagulate, desiccate or fulgurate. Electricity is used to cause thermal destruction of tissue through dehydration, coagulation, or vaporization. The tissue acts as a resistance to the passing current and converts it into heat. High-frequency electro surgery and electro cautery are the two types of electrosurgeries used.

Electro surgery has a wide range of applications in teeth related procedures, laparoscopy, and chronic diseases (related to kidney and abdomen, among others), with dermatological treatments being the most prominent among others. According to World Health Organization (WHO), one in every three cancer patients suffers from skin cancer. This creates a large patient base opting for electro surgery.

Treatment with curettage and electro surgery for skin cancer has a cure rate of around 99 out of 100 for basal cell cancer, making electro surgery a co-therapy for the treatment.

Request For Customization of Research Report @ https://www.coherentmarketinsights.com/insight/request-customization/1069

Easy electro surgery procedures and numerous applications are expected to fuel growth of the electro surgery market

According to World Health Organization (WHO), colorectal cancer is the second most common cancer among men and women. Moreover, according to American Cancer Society, 2017 around 135,430 people are estimated to be diagnosed with colorectal cancer, 40% of which are already at an advanced stage of the cancer.

According to the new report, An Aging World: 2015, published by National Institute on Aging (NIA), 8.5% of the people worldwide (617 million) are 65 years of age or older and are at a greater risk of developing chronic diseases, which in turn, increases demand for electro surgery procedures. Advancements in technology are expected to improve the performance of electrosurgical generators, ensuring delivery of appropriate heat energy for treatment of the patient.

Advancements in technology, growing geriatric population, and increasing prevalence of chronic diseases related to kidneys and heart, among others are few factors that are expected to fuel growth of the market for electro surgery.

Patients with cochlear implants, cardiac and gastric pacemaker implants, and Implantable Cardioverter Defibrillator (ICDs) are not advised to go under electro surgery, as it can lead to fatal adverse effects. This poses as a major restraint for growth of the market.

Inexpensive electro surgery devices and low maintenance costs are expected to boost growth of the electro surgery market

The global electro surgery market is segmented on the basis of instrument type, applications, end user, and geography.

On the basis of instrument type, the global electro surgery market is segmented into:

Monopolar Instruments for Electro surgery

Electrosurgical Electrode Handles

Electrosurgical Electrodes

Electrosurgical Pencils

Monopolar Forceps

Bipolar Instruments for Electrosurgery

Bipolar System

Bipolar Forceps

Electrosurgery Accessories

Suction Coagulators and Irrigation Devices.

Argon Systems and Accessories.

Smoke Evacuation Systems.

Patient Return Electrodes

On the basis of application, the global electro surgery market is segmented into:

General Surgery

Cosmetic Surgery

Orthopedic Surgery

Gynecology Surgery

Urologic Surgery

Cardiovascular Surgery

On the basis of end user, global electro surgery market is segmented into:

Hospitals

Clinics

Ambulatory Surgical Centers

Others

Chronic diseases are the leading cause of death and disability in the U.S. According to Centers for Disease Control and Prevention, chronic diseases are expected to affect an estimated 164 million people living in the U.S. by 2025. According to International Society of Aesthetic Plastic Surgery, top five countries namely, the U.S., Brazil, Japan, Italy, and Mexico account for 41.4% of the world’s cosmetic procedures, followed by Russia, India, Turkey, Germany, and France. 2015.

The U.S. is the largest market for electro surgery in North America. This is attributed to the country accounting for the highest number of cosmetic procedures, with 1.4 million surgical and 2.6 million non-surgical procedures. Moreover, the country had 6,500 active plastic surgeons, which is the highest in the world, followed by Brazil with 5,500 and China with 2,800 plastic surgeons according to International Society of Aesthetic Plastic Surgery (ISAPS), 2015. This in turn, drives growth of the market for electro surgery in North America. Other factors driving growth of the market in the region include increasing obesity, provisions of the Affordable Care Act that provides favorable reimbursement for use of electro surgery, and growing geriatric population—highly susceptible to chronic diseases due to weak immune systems. Asia Pacific is expected to exhibit the highest growth rate due of increasing demand for cosmetic procedures and improving healthcare infrastructure. India and South Korea were among top five countries to have performed surgical and non-surgical cosmetic procedures in 2015 according to ISAPS.

Mergers and acquisitions leading to market consolidation

Key players operating in the electro surgery market include ERBE Elektromedizin GmbH, BOWA-electronic GmbH & Co. KG, Bovie Medical Corporation, and CONMED Corporation. In 2017, Ethicon Endo-Surgery, Inc. acquired Megadyne Medical Products, Inc. Also, in 2017, U.S. Endoscopy, a leader in endoscopy device design and manufacturing, acquired Genii, Inc.

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Mr. Shah

Coherent Market Insights

1001 4th Ave, #3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: [email protected]

#Electrosurgery MarketElectrosurgery trendsElectrosurgery growthElectrosurgery insightsElectrosurgery outlook

0 notes

sumit76652-blog · 6 years ago

Text

Electrosurgery Market - Global Industry Insights, Trends, Outlook and Opportunity Analysis, 2018-2026

For More Information @ https://www.coherentmarketinsights.com/insight/request-pdf/1069

Treatment with curettage and electro surgery for skin cancer has a cure rate of around 99 out of 100 for basal cell cancer, making electro surgery a co-therapy for the treatment.

Easy electro surgery procedures and numerous applications are expected to fuel growth of the electro surgery market

Inexpensive electro surgery devices and low maintenance costs are expected to boost growth of the electro surgery market

The global electro surgery market is segmented on the basis of instrument type, applications, end user, and geography.

On the basis of instrument type, the global electro surgery market is segmented into:

Monopolar Instruments for Electro surgery

Electrosurgical Electrode Handles

Electrosurgical Electrodes

Electrosurgical Pencils

Monopolar Forceps

Bipolar Instruments for Electrosurgery

Bipolar System

Bipolar Forceps

Electrosurgery Accessories

Suction Coagulators and Irrigation Devices.

Argon Systems and Accessories.

Smoke Evacuation Systems.

Patient Return Electrodes

On the basis of application, the global electro surgery market is segmented into:

General Surgery

Cosmetic Surgery

Orthopedic Surgery

Gynecology Surgery

Urologic Surgery

Cardiovascular Surgery

On the basis of end user, global electro surgery market is segmented into:

Hospitals

Clinics

Ambulatory Surgical Centers

Others

For More Information @ https://www.coherentmarketinsights.com/ongoing-insight/electrosurgery-market-1069

Mergers and acquisitions leading to market consolidation

Request For Customization @ https://www.coherentmarketinsights.com/insight/request-customization/1069

About Coherent Market Insights:

Mr. Shah

Coherent Market Insights

1001 4th Ave,

#3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: [email protected]

0 notes

market-research-future · 4 years ago

Text

Neuromodulation Devices Market Analysis, Overview, Applications, Investment, Price and Profit To 2023

Neuromodulation Devices Market Overview

The Global neuromodulation devices market analysis by size and share is expected to grow at a Health CAGR by 2027. Neuromodulation is a technology that acts directly upon the nerves, thereby, causing alterations in the nerve activity. This is achieved by delivering electrical or pharmaceutical agents directly onto the target area. There is a plethora of neuromodulation applications, which includes deep brain stimulation (DBS) treatment for Parkinson's disease, sacral nerve stimulation for pelvic disorders and incontinence, and spinal cord stimulation for ischemic disorders. Increasing prevalence of neurological disorders like Alzheimer’s and Parkinson’s diseases, and growing geriatric population are the major drivers for the market growth during the forecast period.

The market is projected to demonstrate a sound growth by 2027, surpassing its previous growth records in terms of value with a striking CAGR during the anticipated period (2017 – 2027). According to a recent study report published by the Market Research Future, the global neuromodulation devices market is booming and expected to gain prominence over the forecast period.

Additionally, increasing awareness of about neurological disorders will fuel the market growth during the forecast period. However, high cost of the treatment procedures followed by the stringent government policies and low per capita healthcare expenditures in the middle- and low-income countries may restrain the market growth. According to the Alzheimer's Association in 2017, 5.5 million Americans live with Alzheimer's disease and about 5.3 million of this patient population age is 65 years or more. Moreover, according to the World Health Organization, the number of people who age 65 or older is projected to grow from 524 million in 2010 to approximately 1.5 billion by 2050. Moreover, it was estimated that most of the increase in the geriatric population will be witnessed in the developing countries.

Neuromodulation Devices Market Competitive Analysis

Medtronic (Ireland), Accellent (U.S), St. Jude Medical, Inc. (U.S.), Synapse Biomedical Inc. (U.S.), Nevro Corp (U.S.), DynaMD, Boston Scientific Corporation (U.S.), NeuroSigma, Inc.(U.S.), NeuroPace, Inc. (U.S.), Neuronetics, Inc. (U.S.), Soterix Medical Inc. (U.S), and BioControl Medical (Israel) are some of the prominent players at the forefront of competition in the Global Neuromodulation Devices Market and are profiled in MRFR Analysis.

Characterized by the presence of several well-established and small players, the global neuromodulation devices market appears to be highly competitive and fragmented. International players are expanding their footprint in the developing economy, making it difficult for regional vendors to compete with them, especially in terms of features such as product portfolios, quality, and pricing. The market is witnessing intensified competition which is expected to get more intensified further during the forecast period. The intense competition prevalent in the market dictates the consolidation among marketers.

Well established players incorporate acquisition, collaboration, partnership, expansion, and product launch in order to gain competitive advantage in this market and to maintain their market position.

Medtronic is one of the significant players of the global neuromodulation devices market. The company was founded in 1949 and is headquartered in Ireland. Medtronic’s annual sale in 2015 was USD 20,261 million and reached USD 28,833 million in 2016. Such significant increase in the sales lead to a huge investment in the R&D. In 2016, the company invested 7.7% of its total revenue into the research and development processes.

In October 2016, Medtronic got an approval for its suite of cardiac rhythm and heart failure devices. This advancement gave patients- Medtronic SureScan MR-conditional pacemakers, implantable cardioverter-defibrillators (ICDs) and cardiac resynchronization therapy-defibrillators (CRT-Ds). This helped Medtronic to strengthen its position in the market.

In September 2016, Boston Scientific and EndoChoice Holdings, Inc. announced that the companies have entered into a definitive agreement under which Boston Scientific had agreed to acquire EndoChoice. Upon completion of the transaction, EndoChoice became part of the Boston Scientific endoscopy business.

Neuromodulation Devices Market Regional Analysis

On the regional backgrounds the Americas leads the global neuromodulation devices market owing to a well-developed healthcare sector, huge patient population and presence of the developed technologies like U.S. and Canada which have technological backgrounds and rising healthcare expenditure for facilitating the market growth. Europe is second in the market due to huge patient population, rising government support and increasing awareness about the disease. The Asia Pacific region is the fastest growing region due to the developing economies like India and China which have a developing healthcare sector. On the other hand, the Middle East and Africa have the least market share, especially in the African region due to the presence of poor economies and stringent government within the African region. The Middle East region holds the market within this region due to huge healthcare expenditures.

Browse Full Report at: https://www.marketresearchfuture.com/reports/neuromodulation-devices-market-1337

Browse More Research Reports at:

Calciphylaxis Market Research Report Forecast To 2023 | MRFR

Meralgia Paresthetica Market Research Report - Forecast to 2023 | MRFR

Nystagmus Market Size, Application | Dynamics, 2023

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: [email protected]

0 notes

ketan-wagh121-blog · 5 years ago

Text

Defibrillators Market Segmentation, Application, Technology & Market Analysis Research Report 2026

Global Defibrillators Industry

Latest Report on Defibrillators Market Global Analysis & 2022 Forecast Research Study

Market Insights: The Global defibrillators market is expected to grow at a CAGR of 7.2% during 2017-2022. Defibrillation is the treatment of chronic cardiovascular diseases such as cardiac dysrhythmias, such as non-perfusing ventricular tachycardia (VT) and ventricular fibrillation (VF) through a device called defibrillators. The defibrillators is an electrical device that delivers a dose of electric current to the heart, This depolarizes a critical mass of the heart muscle, terminates the dysrhythmia, and allows normal sinus rhythm to be re-established by the body's natural pacemaker. Global defibrillators market is growing at a very fast pace owing to rising cardiovascular diseases, this is one of the most important factor in the growth of the market. Apart from that increase in number of geriatric population, technological advancement in defibrillators, increasing investment by major players, and high present of unmet medical needs and so on are boosting the global defibrillators market in the forecasted time period. On the other hand preference of drugs over defibrillators, strict FDA regulations and low awareness regarding defibrillators in underdeveloped market is restraining the global defibrillators market. On the other hand development of new MRI labelled devices and growing healthcare expenditure in APAC region may acts as an opportunity in the growth of the market.

Try Sample Report @ https://www.wiseguyreports.com/sample-request/2786807-global-defibrillators-market-research-and-forecast-2017-2022

Geographical Insights Geographically market has been bifurcated into North America, Europe, Asia Pacific and Rest of the World. North America is one the major market for defibrillators in the forecasted time period, owing to increased awareness about public access defibrillator, increased procedure volumes resulting from rapidly aging population, the increased adoption of advanced defibrillators increasing incidence of cardiovascular diseases and sudden cardiac arrest (SCA) in this region. Apart from that, improvement in healthcare expenditure further fuels the sale of home care defibrillators such as automated external defibrillator (AEDs) and wearable external defibrillators. Decrease in the cost of AEDs due to increasing competitions amongst major players is also helps this region to grow. Though, Asia pacific region is projected to witness the fastest growth in this region. Japan is the major country in this region, contributes solely for the AEDs market share. This is a result of awareness about the early prevention of sudden cardiac arrest. Too, increasing expenditures and improving healthcare infrastructures in the emerging markets mainly India and China to overcome the unmet medical needs in these countries have strengthened the market growth. Technological advancements for cost-effective devices in these nations offer a lucrative opportunity for the growth of defibrillator market.

Competitive Insights: The Key Players in the Global defibrillators market Include St. Jude Medical, Bexen Cardio, Biotronik Se & Co. Kg, Boston Scientific, Cardiac Science Corporation, Cardioline Spa, Defibtech, Llc, Ge Healthcare, Heartsine Technologies, Inc., Livanova Plc, Medtronic, Mindray Medical, Nihon Kohden Corporation, Phillips Healthcare, Physio Control Inc., Primedic, Schiller Ag, Sorin Group, Stryker Inc., Zoll Medical Corporation and so on Partnership, R&D, M&A, Product Launch Are The Key Strategy Adopted In The Global defibrillators market.

Market Segmentation: Global defibrillators market is segmented on the basis of Types, end users and regional outlook. 1. Global Defibrillators Market Research and Analysis, By Types 2. Global Defibrillators Market Research and Analysis, By End Users 3. Global defibrillators market Research and Analysis, By Region

OMR Report covers: • Comprehensive research methodology of Global defibrillators market. • This report also includes detailed and extensive market overview with key analyst insights. • Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations. • Analysis of regional regulations and other government policies impacting the Global defibrillators market. • Insights about market determinants which are stimulating the Global defibrillators market. • Detailed and extensive market segments with regional distribution of forecasted revenues. • Extensive profiles and recent developments of market players.

For Detailed Reading Please visit WiseGuy Reports @ https://www.wiseguyreports.com/reports/2786807-global-defibrillators-market-research-and-forecast-2017-2022

Some points from table of content:

REPORT SUMMARY 1.1. RESEARCH METHODS AND TOOLS 1.2. MARKET BREAKDOWN 1.2.1. BY SEGMENTS 1.2.2. BY GEOGRAPHY 1.2.3. BY STAKEHOLDERS 1.2.4. EXCEPTIONS 2. MARKET OVERVIEW AND INSIGHTS 2.1. DEFINITION 2.2. ANALYST INSIGHTS & CURRENT MARKET TRENDS 2.2.1. KEY FINDINGS 2.2.2. RECOMMENDATION 2.2.3. CONCLUSION 2.3. REGULATION 2.3.1.1. UNITED STATES 2.3.1.2. EUROPEAN UNION 2.3.1.3. CHINA 2.3.1.4. INDIA 3. MARKET DETERMINANT 3.1. MOTIVATORS 3.1.1. INCREASING NUMBER OF AGED POPULATION 3.1.2. TECHNOLOGICAL ADVANCEMENT IN DEFIBRILLATOR 3.1.3. INCREASING INVESTMENT BY MAJOR PRIVATE PLAYERS 3.1.4. RISING PREVALENCE OF CARDIOVASCULAR DISEASES 3.2. RESTRAINT 3.2.1. PREFERENCE OF DRUGS OVER DEFIBRILLATORS 3.2.2. STRICT GOVERNMENT REGULATIONS SUCH AS BY FDA 3.2.3. LOW AWARENESS REGARDING DEFIBRILLATORS IN UNDERDEVELOPED MARKET 3.3. OPPORTUNITY 3.3.1. DEVELOPMENT OF NEW MRI LABELLED DEVICES 3.3.2. GROWING HEALTHCARE EXPENDITURE IN APAC REGION 4. MARKET SEGMENTATION 4.1. DEFIBRILLATOR, BY TYPES 4.1.1. MANUAL EXTERNAL DEFIBRILLATOR 4.1.2. AUTOMATED EXTERNAL DEFIBRILLATOR 4.1.3. IMPLANTABLE CARDIOVERTER DEFIBRILLATOR 4.1.3.1. TRANSVENEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (T-ICDS) 4.1.3.2. SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (S-ICDS) 4.1.4. WEARABLE CARDIOVERTER DEFIBRILLATOR DEFIBRILLATOR, BY COMPONENTS 4.1.5. CAPACITORS 4.1.6. INDUCTORS 4.1.7. POWER SUPPLY 4.2. DEFIBRILLATOR, BY END USERS 4.2.1. HOSPITALS 4.2.2. DIAGNOSTIC CENTERS 4.2.3. AMBULATORY SERVICE 4.2.4. HOMECARE 4.2.5. OTHERS

Continued…….

For more information or any query mail at [email protected]

About Us Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.

Also Read: https://www.newsmaker.com.au/news/364890/defibrillators-market-global-industry-analysis-2017-2022#.XuCQ_dUzbIU

0 notes

isiawgr-blog · 7 years ago

Text

Neuromodulation Devices Market: Current Trends, Business Opportunities, Challenges & Global Industry Analysis by 2027

Global Neuromodulation Devices Market – Overview

Neuromodulation is a technology that acts directly upon the nerves, thereby, causing alterations in the nerve activity. This is achieved by delivering electrical or pharmaceutical agents directly onto the target area. There is a plethora of neuromodulation applications, which includes deep brain stimulation (DBS) treatment for Parkinson's disease, sacral nerve stimulation for pelvic disorders and incontinence, and spinal cord stimulation for ischemic disorders. Increasing prevalence of neurological disorders like Alzheimer’s and Parkinson’s diseases, and growing geriatric population are the major drivers for the market growth during the forecast period. According to the Alzheimer's Association in 2017, 5.5 million Americans live with Alzheimer's disease and about 5.3 million of this patient population age is 65 years or more. Moreover, according to the World Health Organization, the number of people who age 65 or older is projected to grow from 524 million in 2010 to approximately 1.5 billion by 2050. Moreover, it was estimated that most of the increase in the geriatric population will be witnessed in the developing countries. Additionally, increasing awareness of about neurological disorders will fuel the market growth during the forecast period. However, high cost of the treatment procedures followed by the stringent government policies and low per capita healthcare expenditures in the middle and low income countries may restrain the market growth.

The Global Neuromodulation Devices Market is growing with a sound pace. According to a recent study report published by the Market Research Future, the global neuromodulation devices market is booming and expected to gain prominence over the forecast period. The market is projected to demonstrate a sound growth by 2027, surpassing its previous growth records in terms of value with a striking CAGR during the anticipated period (2017 – 2027).

Key Players for Neuromodulation Devices Market:

Global Neuromodulation Devices Market - Competitive Analysis

Try Sample Report Here @ https://www.marketresearchfuture.com/sample_request/1337 .

Segments: Global neuromodulation devices market has been segmented on the basis of agents which comprises of electrical, optical and chemical signals others. On the basis of devices include spinal cord stimulation devices, deep brain stimulation devices (DBS), sacral nerve stimulation devices, Vagus nerve stimulation devices and Gastric electric stimulation devices.

Global Neuromodulation Devices Market - Regional Analysis

Get Discount on Report @ https://www.marketresearchfuture.com/check-discount/1337 .

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact: Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune – 411028 Maharashtra, India +1 646 845 9312 Email: [email protected]

#Neuromodulation Devices #Neuromodulation Devices Market Size #Neuromodulation Devices Market Share #Neuromodulation Devices Market Trends #Neuromodulation Devices Market Analysis

0 notes

maximumcollectorloveblr-blog · 7 years ago

Text

Growth of Ventricular Tachycardia Market Projected to Amplify During 2017 - 2025

A sample of this report is available upon request @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=34034

Long-term treatment includes oral antiarrhythmic medication. However, antiarrhythmic agents are not always prescribed due to their severe side effects. Other long-term treatment options are implantation of an implantable cadioverter defibrillator (ICD), ablation procedure using a radiofrequency catheter, and cardiac resynchronization therapy. The catheter ablation procedure sub-segment is expected to expand significantly during the forecast period, owing to promising success rate of the procedure. Rising incidence of cardiac diseases such as cardiomyopathy, myocarditis, and valvular heart disease is anticipated to be the primary factor fueling the ventricular tachycardia market during the forecast period. Moreover, growing geriatric population suffering from heart diseases and changing lifestyle are other factors likely to drive the market in the near future. Furthermore, advancements in technology and improvements in existing treatment therapies are anticipated to fuel the ventricular tachycardia market during the forecast period. However, high cost of treatment is a major factor restraining the market.

To view TOC of this report is available upon request @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=34034

Browse Report : https://www.transparencymarketresearch.com/ventricular-tachycardia-market.html

#Ventricular Tachycardia

0 notes

gmmadrid-blog · 7 years ago

Text

Growth Analysis

Summary

The preceding information will explain Optum’s strategic operational initiatives to respond to the growth phase of the Optum India project. This includes how we plan to expand services with a three phased approach, turn data into information, and create automation through two new systems (Optum 360 and Optum Rx). Since the incentive program has proven to be widely popular in the rural areas, where the majority of the population reside, it is fair to say that these types of initiatives will only continue to grow. At this point in time competition will be locked out for five years as stipulated in the new contract and contingencies have been created in the event of failure to reach quarterly benchmarks and project goals.

Introduction

The first initial project consisted of a pilot project in Uttar Pradesh focused on addressing chronic conditions of patients. This created a win-win-situation for all stakeholders because: (1) the Central government was able to reduce cost of “High Risk” patients, (2) the less experienced providers now have data turned into information as a tool and most importantly (3) it helped the quality of care of the patients. By addressing these chronic conditions, India and Optum are taking measure to prevent post-secondary conditions and or multiple conditions, both of which have been extremely costly to the Indian government as they continue to provide free care for the majority of their population.

One clear example of these measures, based on the pilot project, can be seen in preventative stabilization of hypertension and high cholesterol, which by far make up the bulk of all chronic conditions in India. Preventative measures have already helped decrease the amount of invasive (surgical) procedures in the thousands. These non-invasive treatment plans involving patient education, prescription medications and follow up wellness visits, drastically decrease the amount of invasive cardiac procedures that is costing the Central government $10K per person (in India) versus the average $100 non-invasive preventative care.

With the completion of the initial pilot project in Uttar Pradesh, the end results were a huge success. There was an 83% response from the population of 200 million to engage in the program of which 98% of those patients who were treated and diagnosed with chronic conditions are now registered in the incentive programs. This more than doubled the benchmark initially established in the forecast analysis between Optum and the Central and State governments of India. The success of this program has brought with it much attention due to an article published via the World Health Organization (WHO) along with the media. With so much attention drawn, the concern of competition and replication requires immediate attention.

5 Year Plan

To counter these concerns Optum has already began plans to create three unique projects that will be rolled out in phases as we move towards full implementation of the Optum India project. In India the Central government likes to establish five year plans for its healthcare initiatives. In the case of Optum and its products and services the timing for such initiative is in sync with the government’s new five year plan. Since the Uttar Pradesh pilot project proved to be successful, a five year contract negotiation with Optum is inevitable. While a five year contract creates an advantage for Optum the execution of projects and services must ensure that this project be planned strategically in order to position Optum for contract renewal against any competitors once the contract is over. In doing so, these plans must be well thought out with both infrastructure and structured process linking the BI to quality data and compatibility between systems from the very beginning, making it difficult to transition to any competitor.

Phase l

To execute the India Project, Optum has decided on three phases of implementation for the India project with each phase building on the other creating a snowball effect of costs saving for the Indian government. To begin the first phase will mirror the efforts of the Uttar Pradesh pilot. To accommodate data storage capacity and ETL is already being refined from lessons learned in the pilot to accommodate BI reporting methods on a larger scale. Phase 1 will begin with continuing to address the 4 major epidemics and chronic conditions that is plaguing India which is simultaneously creating the biggest expense to their country’s healthcare system. Phase 1 will begin the collection of patient data to share patient demographic information into the BI architecture to show trend analysis in the treatment and follow-up of patient care. This will serve as platform from which to gather the necessary data, including diagnosis sorted into the International classification of Coding to edition (ICD 10), all in an effort to ramp up the next phase.

Phase II

Since much of the initial data has been collected in phase 1, “Phase 2” will introduce automation with the Optum 360 system. The Optum 360 will prove to be a valuable tool for all of the inexperienced providers who are currently caring for the majority of the population. Optum 360 will bring electronic medical records (EMR) to life, where currently this is non-existent in rural areas. Computer generated records that are able to be accessed online will streamline the entire healthcare system. The Optum 360 automatically creates the codes as the provider is treating the patient even going so far as to make suggestions for labs based on the symptoms. Example for providers in Optum 360: “Would you like to order hemoglobin H1C based on the diagnosis and current symptoms you have inputted.” This technology will help ensure that even the least motivated medical interns who are seeing the bulk of the patients are taking preventative measure in their plan of care and help remind them of the underlying chronic conditions when routine visits occur, thus improving the overall quality of care being delivered.

Phase III

With data, trend analysis, EMR and automation in place, Phase 3 will address the pharmaceutical needs of India. Phase III is focused on the pharmaceutical platform known as Optum Rx. Optum Rx is currently the largest pharmacy benefit managers in the world processing 1.2 billion prescriptions to 66 million members in 67K prescription networks (Optum, 2017). Optum Rx administers pharmacy plans, develops pharmacy networks, negotiates with drug companies for the best medication prices, processes pharmacy claims, provides clinical research and disease management, and finally it help to establish delivery which has recently partnered with Amazon for distribution. In summary Optum Rx offers a complete package of cost effective measures and opportunities to address the country’s pharmaceutical including research, access, and distribution to medications.

Contingency Plans

While demand for the Optum India project is expected to continue, there is no guarantee that phases II and III will be accepted in the final contract and or as successful, since these components were not part of the Uttar Pradesh pilot. To ensure that the ROI is met quarterly milestones have been established to ensure that the project remains on track. In the event that any phase does not meet expectations, a change control board has been established to conduct a full review of processes for the first benchmark missed. If Phase II and III are authorized, similar benchmarks will be reported quarterly as well and possible cancellations when missing a second quarterly benchmark. If the overall goal fails to meet annual expectation benchmarks than a contingency term has been established between the Central Indian government and Optum, to renegotiate the terms of agreement for the upcoming year. Finally regarding project failure the opportunity cost due to such failure would primarily be in the resources utilized that could have been allocated in another market area.

Subjective Probability

There is a slow start between year 1 and year 2 with the introduction of chronic disease intervention. The cost of “High Risk” patients will initially go up in the first year as we begin to focus on identifying and treating those patients who suffer from chronic conditions. These patients will begin a plan of care to treat their underlying condition. At the same time the initial cost of treating “Risk Rising” patients will also go up as those patients will also be treated.

Year 2 is where a sharp decline in “High Risk” will happen as those patients who have been on a treatment plan for over a year attend their annual wellness check-up and they transition over to the “Risk Rising” category. Year two will also include electronic medical records (EMR) automation and better clinical outcomes as we introduce Optum 360.

Finally in year three we will continue to see more patients transition into “Risk Rising” category with clear data to reflect treatment and the introduction of Optum Rx. This will stabilize a downward fall in “High Risk” patients. Ultimately the goal is to move those patients to a “Low Risk” care prevention or “Wellness” (not shown in the bar graph) where the cost is insignificant. At the end of the five year project we hope to position Optum with a contract renegotiation based on the dramatic decrease in the “High Risk” patients greatly reducing the cost of treating those particular patients.

0 notes

strategyr-blog · 8 years ago

Text

The Global Market for Artificial Implants is Projected to Cross US$80 Billion by 2022

Developments in Prosthetic Design and Material Construction Drive the Long-Term Revenue Potential of the Global Artificial Implants Market, According to a New Report by Global Industry Analysts, Inc.

GIA launches a comprehensive analysis of industry segments, trends, growth drivers, market share, size and demand forecasts on the global Artificial Implants market. The global market for Artificial Implants is projected to cross US$80 billion by 2022, driven by effervescent technology innovations and the resulting development of prosthesis with superior design and material construction in a manner that helps reduce the risk of immunogenicity.

Artificial Implants are devices that find use in supporting a damaged biological structure, in strengthening an existing structure or in replacing a damaged or missing structure in the human body. Made from bio-medical materials including silicone or titanium, or natural materials in the human body such as skin or bone, these implants are placed either on the surface of the body or inserted into the body depending upon the structure being addressed. Artificial implants play a significant role in overall medical treatment. With further innovations in technology, the market offers even greater potential for the future.

Various innovative products have joined the fray, and an estimated 3 million people worldwide wear implantable defibrillators and pacemakers, while an estimated 2 million wear cochlear implants. The number of orthopedic procedures is expected to double over the next decade. Aging population the world over, has been a major contributor to the unprecedented growth of orthopedics, specifically in the area of implants, as majority of the conditions affecting the elderly require physical therapy, orthopedic surgery or rehabilitation. For instance, rising incidence of age-related conditions such as osteoarthritis are driving growth of hip and knee implants. Hip replacements through the use of advanced technology are considered as one of the ideal ways, in terms of cost and time, for enhancing quality of life for people suffering from arthritis. Prosthetic limbs and bionic implants are commonly used in treatment of degenerative arthritis or diseased joint due to chronic medical history or to replace a damaged joint.

Likewise, demand for dental solutions has a high correlation with age, with the edentulous population making up for a lucrative target market for dental implants. Over the years, the significance and popularity of specialty and aesthetic dentistry has risen considerably, with more and more emphasis being laid on procedures that not only offer better aesthetic results but also reduce recovery time. Patients and dentists are increasingly adopting dental membrane materials, tissue regeneration and dental bone graft materials, as these are easier to handle and use. Further, surgeons are becoming more aware of the available biologic products that are designed for orthopedic applications.

The introduction of implantable cardioverter defibrillator (ICDs) during the 1980s revolutionized the cardiac care market. Clinical studies additionally validated the device use, offering hope to individuals suffering from arrhythmias. As a result, in the following decades, as patient and physician acceptance gained momentum, several device implantations were made in eligible patient groups. Presently, the large patient base with aging devices throws up attractive opportunities for replacements. Future growth in the market will be driven by replacements of surgically implanted ICDs. ICD devices require replacements due to limited battery life and the tendency of the device to become obsolete over a period of time.

As stated by the new market research report on Artificial Implants, the United States and Europe represent major markets worldwide. Asia-Pacific ranks as the fastest growing market with a CAGR of over 10.5% through the analysis period, led by factors such as growing population and a parallel increase in healthcare burden; strong emphasis on quality of healthcare services; government policy led support for biomaterials R&D for artificial implants; high road and workplace accidents as a result of the lack of stringent safety regulations and guidelines and the ensuing increase in demand for spinal implants; and rise of medical tourism especially for cheap and affordable orthopedic procedures in low cost Asian countries.

Major players in the market include Abiomed Inc., Bicon, LLC, Biotronik SE & Co. KG, Boston Scientific Corporation, Cochlear Limited, Dentsply Sirona, DePuy Synthes Companies, Exactech Inc., GS Medical LLC, Institut Straumann AG, Integra Lifesciences Holdings Corporation, Japan Medical Dynamic Marketing Inc., MED-EL Medical Electronics, Medtronic plc, Nobel Biocare Services AG, RTI Surgical Inc., Showa Ika Kohgyo Co. Ltd, Smith & Nephew Plc, St. Jude Medical Inc., Sonova Holding AG, Stryker Corporation, TTK Healthcare Ltd., Terumo Corporation, Wright Medical Group N.V., and Zimmer Biomet Holdings Inc.

The research report titled "Artificial Implants: A Global Strategic Business Report" announced by Global Industry Analysts Inc., provides a comprehensive review of market trends, issues, drivers, mergers, acquisitions and other strategic industry activities of global companies. The report provides market estimates and projections for major geographic markets such as the US, Canada, Japan, Europe (France, Germany, Italy, UK, Spain, Russia, and Rest of Europe), Asia-Pacific (China, India, and Rest of Asia-Pacific), Latin America (Brazil, and Rest of Latin America), and Rest of World.

To connect with us, visit our LinkedIn page.

#Artificial Implants #Medical Equipment and Supplies

0 notes

market-research-future · 5 years ago

Text

Neuromodulation Devices Market Overview, Segmentation, Vendor Landscape

Neuromodulation Devices Market Regional Analysis

Neuromodulation Devices Market Overview

The Global neuromodulation devices market is growing with a sound pace. According to a recent study report published by the Market Research Future, the global neuromodulation devices market is booming and expected to gain prominence over the forecast period. The market is projected to demonstrate a sound growth by 2027, surpassing its previous growth records in terms of value with a striking CAGR during the anticipated period (2017 – 2027).

According to the Alzheimer's Association in 2017, 5.5 million Americans live with Alzheimer's disease and about 5.3 million of this patient population age is 65 years or more. Moreover, according to the World Health Organization, the number of people who age 65 or older is projected to grow from 524 million in 2010 to approximately 1.5 billion by 2050. Moreover, it was estimated that most of the increase in the geriatric population will be witnessed in the developing countries. Additionally, increasing awareness of about neurological disorders will fuel the market growth during the forecast period. However, high cost of the treatment procedures followed by the stringent government policies and low per capita healthcare expenditures in the middle- and low-income countries may restrain the market growth.

Neuromodulation Devices Market Competitive Analysis

Browse Full Report at: https://www.marketresearchfuture.com/reports/neuromodulation-devices-market-1337

Browse More Research Reports at:

3D Bioprinting Market Report - Forecast to 2023 | MRFR

Global and North America Organic and Natural Feminine Care Market Research Report - Forecast to 2023 | MRFR

Poultry Vaccines Market Size, Trends | Growth Analysis, 2023

About Market Research Future:

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: [email protected]

0 notes

market-research-future · 5 years ago

Text

Neuromodulation Devices Market Trends, Demand, Sales, Profit

Neuromodulation Devices Market Share, Growth and Insights By type (Internal, External), Type by Application (SCS, DBS, VNS, SNS, GES, TENS, TMS), by Biomaterial (Metallic, Polymeric, Ceramic), by End-User (Hospitals, Clinics, Homecare) – Global Forecast Till 2023

Neuromodulation Devices Market Regional Analysis

On the regional backgrounds the Americas leads the global Neuromodulation Devices Market Trends owing to a well-developed healthcare sector, huge patient population and presence of the developed technologies like U.S. and Canada which have technological backgrounds and rising healthcare expenditure for facilitating the market growth. Europe is second in the market due to huge patient population, rising government support and increasing awareness about the disease. The Asia Pacific region is the fastest growing region due to the developing economies like India and China which have a developing healthcare sector. On the other hand, the Middle East and Africa have the least market share, especially in the African region due to the presence of poor economies and stringent government within the African region. The Middle East region holds the market within this region due to huge healthcare expenditures.

Neuromodulation Devices Market Overview

Neuromodulation Devices Market Competitive Analysis

Browse Full Report at: https://www.marketresearchfuture.com/reports/neuromodulation-devices-market-1337

Browse More Research Reports at:

Image Guided Radiotherapy Market Size, Trends | Share Analysis, 2023

Central Pontine Myelinolysis Market Research Report- Forecast to 2023 | MRFR

EMEA Beauty Devices Market Size, Trends | Share Analysis, 2021

About Market Research Future:

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: [email protected]

0 notes

market-research-future · 5 years ago

Text

Asia-Pacific Glaucoma Treatment Market Share, Insights, Growth and Applications

Neuromodulation Devices Market Regional Analysis

On the regional backgrounds the Americas leads the global neuromodulation devices market size owing to a well-developed healthcare sector, huge patient population and presence of the developed technologies like U.S. and Canada which have technological backgrounds and rising healthcare expenditure for facilitating the market growth. Europe is second in the market due to huge patient population, rising government support and increasing awareness about the disease. The Asia Pacific region is the fastest growing region due to the developing economies like India and China which have a developing healthcare sector. On the other hand, the Middle East and Africa have the least market share, especially in the African region due to the presence of poor economies and stringent government within the African region. The Middle East region holds the market within this region due to huge healthcare expenditures.

Neuromodulation Devices Market Overview

Neuromodulation Devices Market Competitive Analysis

Browse More Research Reports at:

Middle East and Africa Orthotic Devices Market Trends Analysis, Size | Share, 2023

Infrared Spectroscopy Devices Market Size, Trends | Growth Analysis, 2023

Asia-Pacific Glaucoma Treatment Market Trends, Size Analysis | Applications, 2023

NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

About Market Research Future:

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: [email protected]

0 notes

market-research-future · 5 years ago

Text

Neuromodulation Devices Market Size, Cost Structure Analysis, Research, Scope

Neuromodulation Devices Market Regional Analysis

Neuromodulation Devices Market Overview

Neuromodulation Devices Market Competitive Analysis

Browse More Research Reports at:

Middle East and Africa Orthotic Devices Market Trends Analysis, Size | Share, 2023

Infrared Spectroscopy Devices Market Size, Trends | Growth Analysis, 2023

Asia-Pacific Glaucoma Treatment Market Trends, Size Analysis | Applications, 2023

About Market Research Future:

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: [email protected]

0 notes

market-research-future · 5 years ago

Text

Neuromodulation Devices Market Growth, Size, Dynamics and | Forecast to 2023

Neuromodulation Devices Market Overview

Neuromodulation Devices Market Competitive Analysis

Medtronic got an approval for its suite of cardiac rhythm and heart failure devices. This advancement gave patients- Medtronic SureScan MR-conditional pacemakers, implantable cardioverter-defibrillators (ICDs) and cardiac resynchronization therapy-defibrillators (CRT-Ds). This helped Medtronic to strengthen its position in the market.

Boston Scientific and EndoChoice Holdings, Inc. announced that the companies have entered into a definitive agreement under which Boston Scientific had agreed to acquire EndoChoice. Upon completion of the transaction, EndoChoice became part of the Boston Scientific endoscopy business.

Neuromodulation Devices Market Regional Analysis

The Asia Pacific region is the fastest growing region due to the developing economies like India and China which have a developing healthcare sector. On the other hand, the Middle East and Africa have the least market share, especially in the African region due to the presence of poor economies and stringent government within the African region. The Middle East region holds the market within this region due to huge healthcare expenditures.

Browse More Research Reports at:

Hybrid Operating Room Market Size Analysis, Trends | Application, 2023

Blood Glucose Test Strip Packaging Market– Forecast to 2021 | MRFR

Clinical Intelligence Market Research Report- Forecast to 2023 | MRFR

About Market Research Future:

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: [email protected]

0 notes